http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2013, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 23 May 2013 08:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/CytRx+to+Present+at+the+Marcum+MicroCap+Conference/8364623.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CytRx+to+Present+at+the+Marcum+MicroCap+Conference/8364623.html for the full story. http://www.streetinsider.com/Press+Releases/CytRx+to+Present+at+the+Marcum+MicroCap+Conference/8364623.html Thu, 23 May 2013 08:30:00 -0400 CYTR A.24436032 http://www.streetinsider.com/Press+Releases/CytRx+to+Present+at+the+Marcum+MicroCap+Conference/8364623.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CytRx+to+Present+at+the+Marcum+MicroCap+Conference/8364623.html for the full story. http://www.streetinsider.com/Press+Releases/CytRx+to+Present+at+the+Marcum+MicroCap+Conference/8364623.html Thu, 23 May 2013 08:30:00 -0400 CYTR A.24436032 http://www.streetinsider.com/Press+Releases/CytRx+Announces+Initial+Results+from+Pharmacokinetics+Clinical+Trial+with+Aldoxorubicin+in+Solid+Tumors/8357244.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CytRx+Announces+Initial+Results+from+Pharmacokinetics+Clinical+Trial+with+Aldoxorubicin+in+Solid+Tumors/8357244.html for the full story. http://www.streetinsider.com/Press+Releases/CytRx+Announces+Initial+Results+from+Pharmacokinetics+Clinical+Trial+with+Aldoxorubicin+in+Solid+Tumors/8357244.html Tue, 21 May 2013 08:30:00 -0400 CYTR A.19385386 http://www.streetinsider.com/Press+Releases/CytRx+Announces+Initial+Results+from+Pharmacokinetics+Clinical+Trial+with+Aldoxorubicin+in+Solid+Tumors/8357244.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CytRx+Announces+Initial+Results+from+Pharmacokinetics+Clinical+Trial+with+Aldoxorubicin+in+Solid+Tumors/8357244.html for the full story. http://www.streetinsider.com/Press+Releases/CytRx+Announces+Initial+Results+from+Pharmacokinetics+Clinical+Trial+with+Aldoxorubicin+in+Solid+Tumors/8357244.html Tue, 21 May 2013 08:30:00 -0400 CYTR A.19385386 http://www.streetinsider.com/Press+Releases/CytRx+Issues+Letter+to+Stockholders+Providing+Business+Update/8353338.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CytRx+Issues+Letter+to+Stockholders+Providing+Business+Update/8353338.html for the full story. http://www.streetinsider.com/Press+Releases/CytRx+Issues+Letter+to+Stockholders+Providing+Business+Update/8353338.html Mon, 20 May 2013 08:30:00 -0400 CYTR http://www.streetinsider.com/Earnings/CytRx+Corp+%28CYTR%29+Posts+Q1+Loss+of+23cShare/8321471.html Visit StreetInsider.com at http://www.streetinsider.com/Earnings/CytRx+Corp+%28CYTR%29+Posts+Q1+Loss+of+23cShare/8321471.html for the full story. http://www.streetinsider.com/Earnings/CytRx+Corp+%28CYTR%29+Posts+Q1+Loss+of+23cShare/8321471.html Thu, 09 May 2013 09:35:20 -0400 CYTR http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CYTRX+CORP++++++++++++++++For%3A+May+09/8321023.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CYTRX+CORP++++++++++++++++For%3A+May+09/8321023.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CYTRX+CORP++++++++++++++++For%3A+May+09/8321023.html Thu, 09 May 2013 08:31:00 -0400 CYTR http://www.streetinsider.com/Press+Releases/CytRx+Reports+2013+First+Quarter+Financial+Results/8320970.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CytRx+Reports+2013+First+Quarter+Financial+Results/8320970.html for the full story. http://www.streetinsider.com/Press+Releases/CytRx+Reports+2013+First+Quarter+Financial+Results/8320970.html Thu, 09 May 2013 08:30:00 -0400 CYTR http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CYTRX+CORP++++++++++++++++For%3A+Mar+31/8320947.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CYTRX+CORP++++++++++++++++For%3A+Mar+31/8320947.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CYTRX+CORP++++++++++++++++For%3A+Mar+31/8320947.html Thu, 09 May 2013 08:29:00 -0400 CYTR http://www.streetinsider.com/Press+Releases/CytRx+Provides+Update+on+Clinical+Programs/8316113.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CytRx+Provides+Update+on+Clinical+Programs/8316113.html for the full story. http://www.streetinsider.com/Press+Releases/CytRx+Provides+Update+on+Clinical+Programs/8316113.html Wed, 08 May 2013 08:30:00 -0400 CYTR http://www.streetinsider.com/Corporate+News/CytRx+Corp+%28CYTR%29+Recommended+to+Continue+Aldoxorubicin+Phase+2b+to+Completion/8306694.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/CytRx+Corp+%28CYTR%29+Recommended+to+Continue+Aldoxorubicin+Phase+2b+to+Completion/8306694.html for the full story. http://www.streetinsider.com/Corporate+News/CytRx+Corp+%28CYTR%29+Recommended+to+Continue+Aldoxorubicin+Phase+2b+to+Completion/8306694.html Mon, 06 May 2013 08:36:28 -0400 CYTR http://www.streetinsider.com/FDA/CytRx+Corp+%28CYTR%29+Recommended+to+Continue+Aldoxorubicin+Phase+2b+to+Completion/8306694.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/CytRx+Corp+%28CYTR%29+Recommended+to+Continue+Aldoxorubicin+Phase+2b+to+Completion/8306694.html for the full story. http://www.streetinsider.com/FDA/CytRx+Corp+%28CYTR%29+Recommended+to+Continue+Aldoxorubicin+Phase+2b+to+Completion/8306694.html Mon, 06 May 2013 08:36:28 -0400 CYTR http://www.streetinsider.com/Press+Releases/CytRx+Receives+Recommendation+from+Data+Safety+Monitoring+Committee+to+Complete+International+Phase+2b+Trial+with+Aldoxorubicin+as+First-Line+Treatment+for+Soft+Tissue+Sarcoma/8306606.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CytRx+Receives+Recommendation+from+Data+Safety+Monitoring+Committee+to+Complete+International+Phase+2b+Trial+with+Aldoxorubicin+as+First-Line+Treatment+for+Soft+Tissue+Sarcoma/8306606.html for the full story. http://www.streetinsider.com/Press+Releases/CytRx+Receives+Recommendation+from+Data+Safety+Monitoring+Committee+to+Complete+International+Phase+2b+Trial+with+Aldoxorubicin+as+First-Line+Treatment+for+Soft+Tissue+Sarcoma/8306606.html Mon, 06 May 2013 08:30:00 -0400 CYTR